Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 ...
BC, OCN, explained that comprehensive disease and treatment education are essential to adherence for patients with breast ...
Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 ...
Stein, MD, professor and co-director of the Acute Leukemia Program at City of Hope in Duarte, California, provides deeper insight into the trial design and key findings in an interview with Targeted ...
Professor Janice Walshe, a medical oncologist, explains how the diagnosis process works when it comes to breast cancer, as ...
The conversion from accelerated approval to traditional approval was supported by data from the phase 3 KEYNOTE-811 trial.
The American Medical Association and more than two dozen other health organizations joined in an amicus brief encouraging the ...
In HER2-positive early breast cancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival versus Herceptin.
Accelerated aging in breast cancer survivors is linked to treatments and tumor characteristics, with implications for ...
Oklahoma House members gave a message of solidarity for Rep. Provenzano; a show of love for another person in a time of so ...
Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback